$3.9B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | RVMD Revolution Medicines Inc | 3.0M | +3.8% | $555M | 14.2% |
| 2 | KYMR Kymera Therapeutics Inc | 3.9M | −29.6% | $444M | 11.4% |
| 3 | XOMA ROYALTY CORPORATION Xoma Royalty Corporation | 7.6M | +193.1% | $323M | 8.3% |
| 4 | MLTX Moonlake Immunotherapeutics | 16.0M | +0.0% | $312M | 8.0% |
| 5 | GHRS Gh Research Plc | 8.7M | +0.0% | $233M | 5.9% |
| 6 | GPCR Structure Therapeutics Inc | 3.4M | −2.7% | $181M | 4.6% |
| 7 | NKTR Nektar Therapeutics | 2.4M | −6.6% | $167M | 4.3% |
| 8 | MIRM Mirum Pharmaceuticals Inc | 1.1M | −33.4% | $124M | 3.2% |
| 9 | XNCR Xencor Inc | 7.1M | +0.0% | $115M | 2.9% |
| 10 | ALKS Alkermes Plc | 2.2M | +7.7% | $113M | 2.9% |
| 11 | GLUE Monte Rosa Therapeutics Inc | 4.5M | +0.0% | $108M | 2.8% |
| 12 | CGEM Cullinan Therapeutics Inc | 5.8M | +0.0% | $105M | 2.7% |
| 13 | PVLA Palvella Therapeutics Inc Ne | 672,789 | −30.0% | $103M | 2.6% |
| 14 | ZYME Zymeworks Inc | 3.6M | −2.3% | $95M | 2.4% |
| 15 | KURA Kura Oncology Inc | 8.4M | +0.0% | $93M | 2.4% |
| 16 | IRON Disc Medicine Inc | 1.2M | −9.3% | $84M | 2.2% |
| 17 | STOK Stoke Therapeutics Inc | 2.5M | +0.0% | $83M | 2.1% |
| 18 | OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc | 5.3M | +0.0% | $66M | 1.7% |
| 19 | ANNX Annexon Inc | 8.7M | +0.0% | $50M | 1.3% |
| 20 | CBIO Crescent Biopharma Inc. | 2.7M | +0.0% | $49M | 1.3% |
| 21 | ACIU Ac Immune Sa | 19.8M | +0.0% | $47M | 1.2% |
| 22 | TYRA Tyra Biosciences Inc | 1.5M | −25.3% | $47M | 1.2% |
| 23 | STRO Sutro Biopharma Inc | 1.3M | +0.0% | $42M | 1.1% |
| 24 | IMCR Immunocore Hldgs Plc | 1.3M | +0.0% | $41M | 1.1% |
| 25 | AVTX Avalo Therapeutics Inc | 2.1M | +27.1% | $38M | 1.0% |
| 26 | FDMT 4D Molecular Therapeutics In | 2.9M | +0.0% | $38M | 1.0% |
| 27 | QTTB Q32 Bio Inc | 2.4M | — | $30M | 0.8% |
| 28 | AVR Anteris Technologies Global | 3.0M | +0.0% | $30M | 0.8% |
| 29 | FHTX Foghorn Therapeutics Inc | 5.8M | +0.0% | $29M | 0.7% |
| 30 | ABSI Absci Corporation | 2.4M | — | $27M | 0.7% |
| 31 | ELDN Eledon Pharmaceuticals Inc | 6.3M | +0.0% | $25M | 0.6% |
| 32 | IVVD Invivyd Inc | 28.2M | +44.3% | $25M | 0.6% |
| 33 | SGMT Sagimet Biosciences Inc | 2.5M | — | $19M | 0.5% |
| 34 | OKUR Onkure Therapeutics Inc | 3.2M | +63.5% | $15M | 0.4% |
| 35 | IMUX Immunic Inc | 765,295 | — | $12M | 0.3% |
| 36 | XFOR X4 Pharmaceuticals Inc | 2.2M | +0.0% | $10M | 0.3% |
| 37 | IMA Imagenebio Inc | 1.1M | +0.0% | $7M | 0.2% |
| 38 | TCRX Tscan Therapeutics Inc | 5.6M | +0.0% | $5M | 0.1% |
| 39 | RACC Research Alliance Corp Iii | 500,000 | — | $5M | 0.1% |
| 40 | MOLN Molecular Partners Ag | 1.4M | +0.0% | $5M | 0.1% |
| 41 | TENX Tenax Therapeutics Inc | 339,549 | +0.0% | $5M | 0.1% |
| 42 | ENTX Entera Bio Ltd | 2.4M | — | $4M | 0.1% |
| 43 | IVA Inventiva Sa | 686,040 | +0.0% | $3M | 0.1% |
| 44 | ENGN Engene Therapeutics Inc | 945,402 | — | $274,072 | 0.0% |